California State Teachers Retirement System (CalSTRS)’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-77,052
Closed -$581K – 3109
2023
Q1
$581K Sell
77,052
-5,624
-7% -$51.1K ﹤0.01% 2227
2022
Q4
$838K Buy
82,676
+884
+1% +$10.2K ﹤0.01% 2021
2022
Q3
$809K Sell
81,792
-13,266
-14% -$146K ﹤0.01% 2034
2022
Q2
$1.01M Buy
95,058
+88,577
+1,367% +$750K ﹤0.01% 1954
2022
Q1
$63K Buy
6,481
+42
+0.7% +$398 ﹤0.01% 2977
2021
Q4
$92K Buy
6,439
+19
+0.3% +$288 ﹤0.01% 3026
2021
Q3
$129K Buy
+6,420
New +$113K ﹤0.01% 2905

Other funds holding ABCL

California State Teachers Retirement System (CalSTRS)'s ABCL Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of AbCellera Biologics (ABCL) in Q2 2023, closing a stake of 77,052 shares — an estimated $581K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ABCL in Q3 2021 and held it in 7 quarters. The position peaked at $1.01M in Q2 2022. 169 funds tracked by Wall St. Rank hold ABCL as of Q2 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining AbCellera Biologics position as of Q2 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 77,052 AbCellera Biologics shares in Q2 2023, an estimated $581K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in AbCellera Biologics in Q3 2021 and held it in 7 quarters.
  • California State Teachers Retirement System (CalSTRS)'s AbCellera Biologics position peaked at $1.01M in Q2 2022.
  • 169 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.